(Date:7/8/2008)...WASHINGTON, July 8, 2008) The American Society of...al recipients of its Alternative Training Pathway ...ctors to encourage the development and implementat... , Thomas Abshire, MD, of Emory University, Don..., and David Sternberg, MD, PhD, of Mount Sinai Sch...
(Date:7/8/2008)...is new executive team will give the men we serve a...aid Carl J. Bentley, President, M.I. Board of ...y 8 /PRNewswire/ -- The Mariners Inn shelter and t...the appointment of Jim Hartz as,chief executive of...., "Both Jim and David are outstanding leaders in...
(Date:7/8/2008)...ecently identified genetic markers, called single ...ed with a small but statistically significant incr... substantially improve the accuracy of existing mo...idual,s risk, according to a study in the July 8 o... Institute . , Risk prediction models provide es...
(Date:7/8/2008)...Will Not Reduce Competition and Will Help to Lower...engthen the Pennsylvania Economy, PITTSBURGH, Jul...rk and,Independence Blue Cross (IBC) testified her...ment public hearing about the combination of,the t...omers, health care,providers, and the communities ...
Breaking Medicine News(10 mins):Health News:Mariners Inn Announces New Executive Leadership 2Health News:Single-nucleotide polymorphisms do not substantially improve risk prediction for breast cancer 2Health News:Highmark and Independence Blue Cross CEOs Say Combination of Highmark and Independence Blue Cross will Provide $1 Billion in New Resources Over Six Years 2(Date:7/8/2008)... NEW YORK, July 8 /- McGraw-Hill...ation resources for the scientific and medical,com... new drug,effectiveness reference to its comprehen...rmacy (http://www.accesspharmacy.com ). Through a...ributed databases generated from clinical,studies,...
(Date:7/8/2008)... - Focalin XR demonstrated better symptom contr...post-dose in primary and secondary endpoints,- Onl...30 minutes post-dose, - Additional analysis sugges... Concerta over 12 hours - Sym...(ADHD) can,significantly impact a child,s ability ...
(Date:7/7/2008)... - Dimebon Significantly Improves Cognition a...ton,s Disease Patients - - Findings Warrant Fur...- Conference Call Scheduled for Today at 5:00 p.m....ll/ -- Medivation, Inc.,(Nasdaq: MDVN ) today ann...,that its investigational drug Dimebon(TM) signifi...
(Date:7/7/2008)... NEW YORK, July 7 /- P...s announced that its subsidiary, PulmoScience,Inc.... DFH-12 product,candidate for the PulmoBind techno...f the lungs., Molecular Imaging uses a molecule d...he body. In the case of PulmoBind, the chosen mole...
Breaking Medicine Technology:McGraw-Hill Professional Launches Drug Effectiveness Resource on AccessPharmacy 2Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 2Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 3Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 4Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 5Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 6Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 7Head-to-Head Study Demonstrates Focalin(R) XR Offers Faster and Better Symptom Control than Concerta(R)1 in Early Part of ADHD Patients' Day 8Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 2Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 3Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 4Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 5Pulmo BioTech Inc. Completes Bio-Distribution Studies 2Pulmo BioTech Inc. Completes Bio-Distribution Studies 3Surgical Care Affiliates and UCSD Medical Center to Partner in Surgical Center 8806 1Surgical Care Affiliates and UCSD Medical Center to Partner in Surgical Center 8806 2Fewer Children Outgrowing Allergies to Milk Eggs 8804 1Fewer Children Outgrowing Allergies to Milk Eggs 8804 2Brief intervention helps emergency patients reduce drinking 8802 1Brief intervention helps emergency patients reduce drinking 8802 2Brief intervention helps emergency patients reduce drinking 8802 3U S Census Bureau Daily Feature for December 26 8800 1...LAMEDA, Calif.--(BUSINESS WIRE)--Jun 21, 2007 - Ad...cessfully produced a human,embryonic stem cell (hE...n Worcester, Massachusetts. This development was a...nd Scientific Development of,Advanced Cell Technol...f the International Society for Stem Cell Research...
...IAMI--(BUSINESS WIRE)--Jun 21, 2007 - Answerthink,...ormed a strategic alliance with,LORENZ Life Scienc...in North America. Answerthink and LORENZ Life Scie...ting best practice submissions,management solution...on SAP technology., Answerthink,s pre-configured E...
Other Medicine Technology:Advanced Cell Technology Develops First Human Embryonic Stem Cell,Line without Destroying an Embryo 2Advanced Cell Technology Develops First Human Embryonic Stem Cell,Line without Destroying an Embryo 3Answerthink and LORENZ Life Sciences Group Announce Strategic,Alliance for the SAP Life Science Industry 2Answerthink and LORENZ Life Sciences Group Announce Strategic,Alliance for the SAP Life Science Industry 3Used following open gallbladder procedure to drain bile. Often attached to Bard bile bag.
Hubbed drains are made of translucent silicone and include a full-length X-ray opaque stripe.
Bard® Channel Drain
Used for percutaneous placement of laparoscopic surgical instruments. Check-Flo® valve provides a secure seal around the instruments to be introduced. Supplied sterile in peel-open packages. Inte
Medicine Products: